MedPath

Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With FIRM Guided Procedures

Not Applicable
Completed
Conditions
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Interventions
Procedure: Standard PVI
Procedure: FIRM-Guided Procedure and PVI
Registration Number
NCT02799043
Lead Sponsor
Abbott Medical Devices
Brief Summary

A prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM-guided procedures in conventional "redo" RF ablation procedures for the treatment of persistent and paroxysmal atrial fibrillation.

Detailed Description

The hypothesis of this study was that Focal Impulse and Rotor Modulation (FIRM) guided procedures will eliminate the source of clinical arrhythmias in subjects with clinical indications for repeat AF ablation procedures.

This study is a prospective, multicenter, randomized, controlled study to assess the safety and effectiveness of FIRM procedures followed by ablation including pulmonary vein isolation versus a standard conventional procedure including pulmonary vein isolation for the redo-treatment of persistent or paroxysmal atrial fibrillation after one failed previous pulmonary vein isolation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
269
Inclusion Criteria
  • Experiencing at least one (1) documented episode of spontaneous persistent or paroxysmal atrial fibrillation during the last 3 months by rhythm strip/ECG.
  • One (1) previous AF ablation (PVI-only - any technology) after Jan-01-2013, but NOT within the last 3 months.
  • Left atrial diameter < 6.0 cm via transthoracic echo or transesophageal echo; or <6.5 cm via CT or MRI with 6 months prior to the procedure.
  • Sustained spontaneous or induced AF (>5 min uninterrupted).
Exclusion Criteria
  • Presence of structural heart disease with clinical significance
  • NYHA Class IV
  • Ejection fraction < 35%
  • Previous AF ablation within the last 3 months
  • ASD closure device, LAA closure device, prosthetic mitral or tricuspid valve, or permanent pacemaker.
  • History of myocardial infarction (MI) within the past three (3) months
  • Atrial clot/thrombus noted within 72 hours of the procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard PVIStandard PVIStandard catheter ablation including pulmonary vein isolation (PVI) procedure.
FIRM-guided Procedure and PVIFIRM-Guided Procedure and PVIFIRM-guided procedure followed by PVI.
Primary Outcome Measures
NameTimeMethod
Freedom From Atrial Fibrillation Atrial Fibrillation (AF), Atrial Tachycardia (AT), or Atrial Flutter (AFL) Recurrence at 12 Months Post Procedure.12 months post procedure

Single procedure freedom from recurrence from 3-12 months post procedure

Freedom From Serious Adverse Events Related to the Procedure12-month post procedure

Freedom from any procedure-related serious adverse event from 0-12 months post procedure

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (24)

Praxisklinik Herz und GefรครŸe Dresden

๐Ÿ‡ฉ๐Ÿ‡ช

Dresden, Germany

Englewood Hospital and Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Englewood, New Jersey, United States

Arizona Heart Rhythm Research Cente

๐Ÿ‡บ๐Ÿ‡ธ

Phoenix, Arizona, United States

Kardiocentrum Frankfurt

๐Ÿ‡ฉ๐Ÿ‡ช

Frankfurt, Main, Germany

The Dr. Mรผller Kliniken

๐Ÿ‡ฉ๐Ÿ‡ช

Munich, Bavaria, Germany

Kardiologische Gemeinschaftspraxis am Park Sanssouci

๐Ÿ‡ฉ๐Ÿ‡ช

Potsdam, Brandenburg, Germany

UKB (Unfallkrankenhaus Berlin)

๐Ÿ‡ฉ๐Ÿ‡ช

Berlin, Germany

Ruhr University Bochum - Heart and Diabetes Center North Rhine-Westphalia

๐Ÿ‡ฉ๐Ÿ‡ช

Bad Oeynhausen, Germany

Northwestern University - Bluhm Cardiovascular Institute

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Ohio State University

๐Ÿ‡บ๐Ÿ‡ธ

Columbus, Ohio, United States

Johns Hopkins Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

University of Pittsburgh Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Pittsburgh, Pennsylvania, United States

Ventura Cardiology Consultants

๐Ÿ‡บ๐Ÿ‡ธ

Ventura, California, United States

Broward Health

๐Ÿ‡บ๐Ÿ‡ธ

Fort Lauderdale, Florida, United States

Loyola University

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

University Hospital of Antwerp

๐Ÿ‡ง๐Ÿ‡ช

Antwerp, Flanders, Belgium

University of Pennsylvania Health System

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Leipzig Heart Institute GmbH

๐Ÿ‡ฉ๐Ÿ‡ช

Leipzig, Saxony, Germany

Furth Medical Clinic for Heart and Lung Diseases

๐Ÿ‡ฉ๐Ÿ‡ช

Fรผrth, Bavaria, Germany

St. Vincent's HealthCare

๐Ÿ‡บ๐Ÿ‡ธ

Jacksonville, Florida, United States

Klinikum Coburg

๐Ÿ‡ฉ๐Ÿ‡ช

Coburg, Bavaria, Germany

Luebeck University Heart Center

๐Ÿ‡ฉ๐Ÿ‡ช

Lรผbeck, Schleswig-Holstein, Germany

Medical Center Rotterdam (Erasmus MC)

๐Ÿ‡ณ๐Ÿ‡ฑ

Rotterdam, South Holland, Netherlands

Virginia Heart

๐Ÿ‡บ๐Ÿ‡ธ

Falls Church, Virginia, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath